Skip to main navigation Skip to search Skip to main content

A Multicentre phase 3 randomised trial comparing docetaxel administered either weekly or every three weeks in combination with prednisolone versus mitoxantrone incombination with prenisolone for metaststic hormonr refractory prostate cancer

Project Details

Short titleA Multicentre phase 3 randomised trial comparing docetaxel administered either weekly or every three weeks in combination with prednisolone versus mitoxantrone incombination with prenisolone for metaststic hormonr refractory prostate cancer
StatusFinished
Effective start/end date18/12/00 → 17/12/04

Funding

  • AVENTIS PHARMA LTD